These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16091650)

  • 1. [The place of diuretics in the treatment of chronic heart failure. Part I].
    Sidorenko BA; Preobrazhenskiĭ DV; Batyraliev TA; Pershukov IV; Makhmutkhodzhaev SA
    Kardiologiia; 2005; 45(8):76-83. PubMed ID: 16091650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torasemide in chronic heart failure: results of the TORIC study.
    Cosín J; Díez J;
    Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long term effects of loop diuretics in heart failure.
    Krück F
    Drugs; 1991; 41 Suppl 3():60-8. PubMed ID: 1712715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Torasemide--new generation loop diuretic: clinical pharmacology and therapeutic application].
    Preobrazhenskiĭ DV; Sidorenko BA; Tarykina EV; Batyraliev TA; Marenich AV
    Kardiologiia; 2006; 46(10):75-86. PubMed ID: 17159856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changing views on the place of loop and thiazide diuretics in the treatment of chronic heart failure. Part II. Influence on outcomes and clinical application].
    Sidorenko BA; Preobrazhesnkiĭ DV; Bataraliev TA; Pershukov IV; Makhmutkhodzhaev SA
    Kardiologiia; 2005; 45(9):99-104. PubMed ID: 16234805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update: prolonged-release torasemide].
    Acuña C
    Drugs Today (Barc); 2010 Jul; 46 Suppl E():1-15. PubMed ID: 20882198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diuretic therapy in heart failure].
    Splendiani G; Condò S
    G Ital Nefrol; 2006; 23 Suppl 34():S74-6. PubMed ID: 16634001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
    Manolis A; Kallistratos M; Doumas M
    Curr Pharm Des; 2021; 27(23):2714-2721. PubMed ID: 33823773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure.
    Steuber TD; Janzen KM; Howard ML
    Pharmacotherapy; 2020 Sep; 40(9):924-935. PubMed ID: 32639593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
    Rosenberg J; Gustafsson F; Galatius S; Hildebrandt PR
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):301-6. PubMed ID: 16189620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC
    Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
    Liu C; Liu G; Zhou C; Ji Z; Zhen Y; Liu K
    Can J Cardiol; 2007 Sep; 23(11):865-8. PubMed ID: 17876376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Spannheimer A; Müller K; Falkenstein P; Reitberger U; Gutzwiller F; Follath F
    Praxis (Bern 1994); 2002 Sep; 91(37):1467-75. PubMed ID: 12360682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do diuretics differ in terms of clinical outcome in congestive heart failure?
    Follath F
    Eur Heart J; 1998 Dec; 19 Suppl P():P5-8. PubMed ID: 9886706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.
    Sica DA; Gehr TW
    Clin Pharmacokinet; 1996 Mar; 30(3):229-49. PubMed ID: 8882303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination diuretic therapy in severe congestive heart failure.
    Dormans TP; Gerlag PG; Russel FG; Smits P
    Drugs; 1998 Feb; 55(2):165-72. PubMed ID: 9506239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of Diuretic Therapy in Cardiology Practice].
    Morozova TE; Yudina IY
    Kardiologiia; 2016 Sep; 56(9):80-83. PubMed ID: 28290870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.